P Brühl

A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses

Martin Spruth, Otfried Kistner, Helga Savidis-Dacho et al. · Vaccine · 2005 · 122 citations · Full text

Vaccination, Vaccine Development, Vaccine Target +7

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses

Otfried Kistner, M. Keith Howard, Martin Spruth et al. · Vaccine · 2007 · 101 citations · Full text

Vaccination, Vaccine Development, Immunology +7

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger et al. · The Lancet Infectious Diseases · 2013 · 100 citations

Vaccination, Vaccine Safety, Vaccine Development +9

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection

S. Coulibaly, P Brühl, Josef Mayrhofer et al. · Virology · 2005 · 80 citations

Vaccination, Vaccine Safety, Vaccinology +8

Immunogenicity and Safety of Defective Vaccinia Virus Lister: Comparison with Modified Vaccinia Virus Ankara

Bertram T. Ober, P Brühl, Michaela Schmidt et al. · Journal of Virology · 2002 · 65 citations · Full text